Skip to main content

Corvus Pharmaceuticals, Inc.

CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626971

No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Corvus Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+1 vs. Q2 2022
Shares held
22.1M
−3.51M (−13.7%) vs. Q2 2022
Total value
$18.1M
−$7.27M (−28.7%) vs. Q2 2022
New holders
6
10 more added
Sold out
5
12 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 48 institutions
Q1 2021: 49 institutionsQ2 2021: 50 institutionsQ3 2021: 61 institutionsQ4 2021: 62 institutionsQ1 2022: 57 institutionsQ2 2022: 47 institutionsQ3 2022: 48 institutionsQ4 2022: 42 institutionsQ1 2023: 37 institutionsQ2 2023: 52 institutionsQ3 2023: 52 institutionsQ4 2023: 48 institutionsQ1 2024: 47 institutionsQ2 2024: 47 institutionsQ3 2024: 62 institutionsQ4 2024: 86 institutionsQ1 2025: 88 institutionsQ2 2025: 92 institutionsQ3 2025: 103 institutionsQ4 2025: 124 institutionsQ1 2026: 164 institutionsQ2 2026: 173 institutions
Value heldQ3 2022: $18.1M
Q1 2021: $62.8MQ2 2021: $63.2MQ3 2021: $136.4MQ4 2021: $66.7MQ1 2022: $44.9MQ2 2022: $25.4MQ3 2022: $18.1MQ4 2022: $18.2MQ1 2023: $18.9MQ2 2023: $44.6MQ3 2023: $28.0MQ4 2023: $33.8MQ1 2024: $31.9MQ2 2024: $50.2MQ3 2024: $158.5MQ4 2024: $202.0MQ1 2025: $115.4MQ2 2025: $167.1MQ3 2025: $312.7MQ4 2025: $359.4MQ1 2026: $1.02BQ2 2026: $1.06B
Institutions holding CRVS and their total value by quarter
QuarterHoldersValue
Q2 2026173$1.06B
Q1 2026164$1.02B
Q4 2025124$359.4M
Q3 2025103$312.7M
Q2 202592$167.1M
Q1 202588$115.4M
Q4 202486$202.0M
Q3 202462$158.5M
Q2 202447$50.2M
Q1 202447$31.9M
Q4 202348$33.8M
Q3 202352$28.0M
Q2 202352$44.6M
Q1 202337$18.9M
Q4 202242$18.2M
Q3 202248$18.1M
Q2 202247$25.4M
Q1 202257$44.9M
Q4 202162$66.7M
Q3 202161$136.4M
Q2 202150$63.2M
Q1 202149$62.8M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q2 2022.

Institutions holding CRVS in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC6,943,654$5.68M0.11%00.0%Unchanged
Adams Street Partners LLC3,275,616$2.68M0.73%00.0%Unchanged
CHI Advisors LLC2,384,402$1.95M0.52%+170,218+7.7%Added
Millennium Management LLC2,265,312$1.85M0.00%−422,631−15.7%Reduced
BVF Inc1,370,947$1.12M0.05%00.0%Unchanged
Vanguard Group Inc1,259,906$1.03M0.00%−7,846−0.6%Reduced
Renaissance Technologies LLC975,519$798.0K0.00%+12,587+1.3%Added
Telemetry Investments, L.L.C.522,009$427.0K0.70%+61,906+13.5%Added
BlackRock Inc.502,942$411.0K0.00%−2,624−0.5%Reduced
Artal Group S.A.500,000$409.0K0.02%00.0%Unchanged
Two Sigma Advisers, LP480,100$393.0K0.00%+106,700+28.6%Added
Two Sigma Investments, LP429,708$352.0K0.00%+68,674+19.0%Added
Geode Capital Management, LLC298,460$244.0K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC159,300$130.0K0.00%00.0%Unchanged
Acadian Asset Management LLC142,160$115.0K0.00%00.0%Unchanged
State Street Corp112,603$92.0K0.00%00.0%Unchanged
Jackson Square Capital, LLC63,773$52.0K0.03%00.0%Unchanged
Northern Trust Corp52,226$43.0K0.00%00.0%Unchanged
Hikari Power Ltd49,959$41.0K0.00%00.0%Unchanged
Bailard, Inc.39,998$33.0K0.00%+39,998New
Morgan Stanley39,317$32.0K0.00%−10,031−20.3%Reduced
Dimensional Fund Advisors LP37,051$30.0K0.00%−195,766−84.1%Reduced
LMR Partners LLP30,000$25.0K0.00%00.0%Unchanged
UBS Group AG22,656$18.0K0.00%+85+0.4%Added
Jane Street Group, LLC20,775$17.0K0.00%+20,775New
Goldman Sachs Group Inc17,261$14.0K0.00%−22,589−56.7%Reduced
Simplex Trading, LLC16,050$13.0K0.00%−9,548−37.3%Reduced
Susquehanna Fundamental Investments, LLC13,790$11.0K0.00%+13,790New
Tower Research Capital LLC (TRC)11,668$10.0K0.00%+2,335+25.0%Added
Mercer Global Advisors Inc10,550$9.00K0.00%00.0%Unchanged
Envestnet Asset Management Inc10,500$9.00K0.00%00.0%Unchanged
Leonteq Securities AG10,000$8.19K0.00%+2,000+25.0%Added
Wolverine Trading, LLC10,688$8.00K0.00%+10,688New
Group One Trading, L.P.7,049$6.00K0.00%−21,748−75.5%Reduced
Whittier Trust Co of Nevada Inc4,200$3.00K0.00%00.0%Unchanged
JPMorgan Chase & Co2,786$2.00K0.00%+818+41.6%Added
TCI Wealth Advisors, Inc.800$1.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,100$1.00K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.1,750$1.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA99$810.00%−1,125−91.9%Reduced
Barclays PLC1$00.00%−9,670−100.0%Reduced
Citigroup Inc526$00.00%−158−23.1%Reduced
Bank of America Corp254$00.00%−209−45.1%Reduced
Wells Fargo & Company229$00.00%+11+5.0%Added
Parallel Advisors, LLC20$00.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC25$00.00%00.0%Unchanged
Royal Bank of Canada272$00.00%+272New
China Universal Asset Management Co., Ltd.436$00.00%+436New
Tang Capital Management LLC0$00.00%−3,301,709−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−11,355−100.0%Sold out
Meeder Asset Management Inc0$00.00%−1,984−100.0%Sold out
Optimum Investment Advisors0$00.00%−1,000−100.0%Sold out
Total Clarity Wealth Management, Inc.0$00.00%−500−100.0%Sold out